New book by Larry Connors Click here Improve your trading - See how
The Deerfield, Illinois-based company's sales for the month were $5.65 billion, an increase of 9.4%, compared to $5.16 billion in the year-ago period.
For the month of October, Walgreen's pharmacy sales rose 9.3%, while comparable pharmacy sales advanced 5%. Comparable pharmacy sales were positively impacted by 1.0 percentage points due to seasonal flu shots, and negatively impacted by 2.2 percentage points due to generic drug introductions in the last 12 months.
Further, prescriptions filled at comparable stores increased 8.6% in October, including 2.4 percentage points due to seasonal flu shots and 1.3 percentage points due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 66.3% of total sales for the month.
The company noted that the impact of calendar day shifts had a negative effect on October, which had one less Wednesday and one extra Saturday compared to October 2008. Calendar shifts negatively impacted total comparable store sales by 1.1 percentage points, comparable pharmacy sales by 1.7 percentage points and prescriptions filled in comparable stores by 1.7 percentage points.
Year-to-date, calendar sales totaled $53.28 billion, up 7.6% from $49.51 billion in the same period last year. Walgreens fiscal 2010 year-to-date sales for the first two months amounted to $11 billion.
For the preceding month of September, the company reported a 5.3% increase in sales at comparable stores. Sales grew 10.3% to $5.349 billion from $4.849 billion for the same month in 2008.
During October, Walgreen, which also operates worksite health centers, home care facilities, opened 69 stores, including eight re-locations. As at Octpber 31, Walgreens operated 7,603 locations in all 50 states, the District of Columbia, Puerto Rico and Guam.
Among Walgreen's peers, Rite Aid Corp. (RAD | Quote | Chart | News | PowerRating) reported october same-store sales decline of 0.5%. The Camp Hill, Pennsylvania-based Rite Aid's June front-end same-store sales dropped 2.7%, while pharmacy same-store sales, which included an approximate 200 basis points negative impact from new generic introductions, edged up 0.5%.
Rite Aid's total drugstore sales for the month decreased 1.7% to $1.962 billion from $1.997 billion in the comparable period last year.
WAG is currently trading at $38.80, up $0.09 or 0.23%. In the past 52 weeks, the stock has been trading in a range of $21.28-$40.69.
For comments and feedback: contact editorial@rttnews.com Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
